D3446
Dipeptidyl Peptidase IV human
recombinant, expressed in Sf9 cells
Manufacturer: Sigma Aldrich
Synonym(S): CD26, DPPIV, Dipeptidyl aminopeptidase IV, Glycoprotein GP110
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μG | D3446-10-μG | In Stock | ₹ 82,206.60 |
D3446 - 10 μG
In Stock
Quantity
1
Base Price: ₹ 82,206.60
GST (18%): ₹ 14,797.188
Total Price: ₹ 97,003.788
recombinant
expressed in Sf9 cells
Quality Level
200
form
solution
specific activity
≥4,000 units/μg protein
mol wt
124 kDa
concentration
≥0.01 mg/mL
UniProt accession no.
P27487
relevant disease(s)
cancer (lymphoma, prostate and colon cancer)
shipped in
dry ice
storage temp.
−70°C
Related Products
Description
- General description: Dipeptidyl Peptidase IV (DPP4) is mapped to human chromosome 2q24.2.[1] It comprises the N-glycosylation sites located in the β-propeller domain.[2]
- Application: Dipeptidyl Peptidase IV human has been used in DPP-IV inhibitory activity assay of quinoa protein concentrate digest.[3]
- Biochem/physiol Actions: Dipeptidyl Peptidase IV (DPP4) mediates the activation of T-cells. It is also a potential biomarker for lymphoma, thyroid, prostate and colon cancer.[1]
- Unit Definition: One unit will hydrolyze 1.0 picomole of Ala-Pro-AMC per minute at pH 7.5 at 25 deg °C
- Physical form: Supplied as a solution in 45 mM Tris-HCl, pH 8.0, 124 mM NaCl, 2.4 mM KCl, 225 mM imidazole and 10% glycerol.
- Other Notes: View more information on Dipeptidyl Peptidase IV at www.sigma-aldrich.com/enzymeexplorer.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P264 - P280 - P302 + P352 - P305 + P351 + P338 - P308 + P313
Hazard Classifications
Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
recombinant: expressed in Sf9 cells
Quality Level: 200
form: solution
specific activity: ≥4,000 units/μg protein
mol wt: 124 kDa
concentration: ≥0.01 mg/mL
UniProt accession no.: P27487
relevant disease(s): cancer (lymphoma, prostate and colon cancer)
shipped in: dry ice
storage temp.: −70°C
recombinant:
expressed in Sf9 cells
Quality Level:
200
form:
solution
specific activity:
≥4,000 units/μg protein
mol wt:
124 kDa
concentration:
≥0.01 mg/mL
UniProt accession no.:
P27487
relevant disease(s):
cancer (lymphoma, prostate and colon cancer)
shipped in:
dry ice
storage temp.:
−70°C
recombinant: __
Quality Level: 200
form: powder
specific activity: __
mol wt: __
concentration: __
UniProt accession no.: __
relevant disease(s): __
shipped in: __
storage temp.: −20°C
recombinant:
__
Quality Level:
200
form:
powder
specific activity:
__
mol wt:
__
concentration:
__
UniProt accession no.:
__
relevant disease(s):
__
shipped in:
__
storage temp.:
−20°C
recombinant: __
Quality Level: 200
form: powder
specific activity: __
mol wt: __
concentration: __
UniProt accession no.: __
relevant disease(s): __
shipped in: __
storage temp.: −20°C
recombinant:
__
Quality Level:
200
form:
powder
specific activity:
__
mol wt:
__
concentration:
__
UniProt accession no.:
__
relevant disease(s):
__
shipped in:
__
storage temp.:
−20°C
recombinant: __
Quality Level: __
form: __
specific activity: __
mol wt: __
concentration: __
UniProt accession no.: __
relevant disease(s): __
shipped in: __
storage temp.: __
recombinant:
__
Quality Level:
__
form:
__
specific activity:
__
mol wt:
__
concentration:
__
UniProt accession no.:
__
relevant disease(s):
__
shipped in:
__
storage temp.:
__